alendronate has been researched along with estriol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, J | 1 |
Colao, A; Lombardi, G; Orio, F; Palomba, S; Russo, T; Zullo, F | 1 |
Aso, T; Obayashi, S; Terauchi, M | 1 |
1 review(s) available for alendronate and estriol
Article | Year |
---|---|
[Comparative analyses on osteoporosis guidelines in Japan, EU and USA].
Topics: Alendronate; Calcitonin; Clinical Trials as Topic; Drug Approval; Estriol; Etidronic Acid; Europe; Humans; Isoflavones; Japan; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; United States; Vitamin K 2 | 2002 |
1 trial(s) available for alendronate and estriol
Article | Year |
---|---|
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.
Topics: Alendronate; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Femur; Half-Life; Humans; Hysterectomy; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Placebos | 2004 |
1 other study(ies) available for alendronate and estriol
Article | Year |
---|---|
Estriol, conjugated equine estrogens, and alendronate therapy for osteoporosis.
Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Estriol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Treatment Outcome | 2006 |